Insmed Drug Patent Portfolio

Insmed owns 1 orange book drug protected by 1 US patent Given below is the list of Insmed's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5681818 Therapeutic uses of human somatomedin carrier proteins 28 Oct, 2014 Expired


Insmed's Family Patents


Family Patents



Insmed Drug List

Given below is the complete list of Insmed's drugs and the patents protecting them.


1. Iplex

Iplex is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5681818 Therapeutic uses of human somatomedin carrier proteins 28 Oct, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Iplex's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Insmed News

Insmed receives FDA clearance for potential blockbuster Brinsupri - Pharmaceutical Technology

13 Aug, 2025

Insmed's Brinsupri: A Major Success in an Overlooked Market - AInvest

12 Aug, 2025

Insmed receives US authorization for lung disease medication expected to be a major success - Yahoo Finance

12 Aug, 2025

Insmed receives US authorization for lung disease medication expected to be a major success | BioPharma Dive

12 Aug, 2025

See More